Published in Infection on October 01, 2002
Isolation of Schineria sp. from a man. Emerg Infect Dis (2007) 1.37
Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity. Lipids Health Dis (2010) 0.95
Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential. Postgrad Med J (2007) 0.90
Maggots as potential vector for pathogen transmission and consequences for infection control in waste management. GMS Hyg Infect Control (2015) 0.75
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med (2000) 3.77
Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis (1982) 3.36
Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis (1990) 2.52
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis. Mol Microbiol (2001) 2.20
Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest (1984) 2.11
Spinal epidural abscess in clinical practice. QJM (2007) 2.00
Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother (1994) 1.89
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med (2001) 1.88
Prognostic value of procalcitonin in community-acquired pneumonia. Eur Respir J (2010) 1.83
Predictive value of cerebrospinal fluid (CSF) lactate level versus CSF/blood glucose ratio for the diagnosis of bacterial meningitis following neurosurgery. Clin Infect Dis (1999) 1.82
Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis (1992) 1.81
Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis? J Clin Microbiol (2003) 1.79
The role of diabetes mellitus in patients with bloodstream infections. Swiss Med Wkly (2008) 1.69
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect (2006) 1.66
Erythema of the proximal nailfold in HIV-infected patients. J Am Acad Dermatol (1996) 1.59
Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection (2004) 1.58
Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun (1996) 1.57
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia. Eur Respir J (2010) 1.57
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Natural history of the Naegeli-Franceschetti-Jadassohn syndrome and further delineation of its clinical manifestations. J Am Acad Dermatol (1993) 1.52
Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis. Crit Care Med (1990) 1.52
In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother (1995) 1.50
Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae. J Hosp Infect (2010) 1.49
Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect (2006) 1.45
Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother (1991) 1.44
Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis (1995) 1.43
[Telemedicine: perspectives and multidisciplinary approach]. Schweiz Med Wochenschr (2000) 1.42
Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. AIDS (1996) 1.42
Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest (1986) 1.41
Infectious complications in drug addicts: seven-year review of 269 hospitalized narcotics abusers in Switzerland. Rev Infect Dis (1989) 1.40
[Ross syndrome]. Hautarzt (1992) 1.39
Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother (1994) 1.37
Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37
Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space. Antimicrob Agents Chemother (1998) 1.37
Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen. Eur J Clin Microbiol Infect Dis (2007) 1.34
Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant (1999) 1.32
Broad-range PCR in selected episodes of prosthetic joint infection. Infection (2009) 1.29
Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother (1998) 1.27
Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions. Clin Infect Dis (1993) 1.27
Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii. Am J Med (1998) 1.26
Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol (1985) 1.24
Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants. Rev Infect Dis (1988) 1.21
The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance. A review. Dermatologica (1981) 1.20
Trypanosoma brucei brucei: a model for cerebral trypanosomiasis in mice--an immunological, histological and electronmicroscopic study. Clin Exp Immunol (1980) 1.20
Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers. Infect Control Hosp Epidemiol (2008) 1.20
Urine analysis performed by flow cytometry: reference range determination and comparison to morphological findings, dipstick chemistry and bacterial culture results--a multicenter study. Clin Nephrol (2001) 1.19
Pneumocystis carinii pneumonia in human immunodeficiency virus (HIV)-positive and HIV-negative immunocompromised patients. Clin Infect Dis (1999) 1.19
Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol (1998) 1.18
Duodenal bacterial overgrowth during treatment in outpatients with omeprazole. Gut (1994) 1.16
The course of Plasmodium chabaudi chabaudi infections in interferon-gamma receptor deficient mice. Parasite Immunol (1997) 1.16
Identification of Neisseria gonorrhoeae in the routine venerelogical laboratory: Comparative study of coagglutination, direct immunofluorescence, and sugar fermentation reaction. Br J Vener Dis (1980) 1.13
Atrophoderma of Pasini and Pierini. Clinical and histopathologic findings and antibodies to Borrelia burgdorferi in thirty-four patients. J Am Acad Dermatol (1994) 1.12
Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study. Arch Intern Med (2000) 1.12
Necessity of screening of both the nose and the throat to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit. J Clin Microbiol (2008) 1.12
In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results. Diagn Microbiol Infect Dis (1992) 1.11
Comparison of the DiversiLab repetitive element PCR system with spa typing and pulsed-field gel electrophoresis for clonal characterization of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2011) 1.10
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA. J Antimicrob Chemother (1994) 1.10
The role of the mosquito peritrophic membrane in bloodmeal digestion and infectivity of Plasmodium species. J Parasitol (1992) 1.10
Corynebacterium tuberculostearicum: a potentially misidentified and multiresistant Corynebacterium species isolated from clinical specimens. J Clin Microbiol (2012) 1.09
Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia. J Infect Dis (1991) 1.09
Toxocara canis: a labile antigenic surface coat overlying the epicuticle of infective larvae. Exp Parasitol (1992) 1.09
Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis (2009) 1.08
Nematode surface coats: actively evading immunity. Parasitol Today (1992) 1.08
Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital. Infection (2008) 1.07
Pharmacokinetics and pharmacodynamics of levofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in human skin blister fluid. Antimicrob Agents Chemother (2000) 1.07
Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies. Rev Infect Dis (1983) 1.07
CD14, new aspects of ligand and signal diversity. Microbes Infect (2000) 1.07
Function of soluble CD14 in serum from patients with septic shock. J Infect Dis (1996) 1.06
Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J Neurosci (1997) 1.06
LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14. J Leukoc Biol (1995) 1.05
Which Neisseria? Br J Vener Dis (1978) 1.05
Mu-opiate receptor and Beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology (2004) 1.04
Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis (2005) 1.04
Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats. J Antimicrob Chemother (1993) 1.03
Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. J Immunol Methods (1997) 1.03
Salmonella infection in total hip replacement: tests to predict the outcome of antimicrobial therapy. Scand J Infect Dis (1990) 1.03
Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg (2013) 1.03
Disordered calcium homeostasis of sepsis: association with calcitonin precursors. Eur J Clin Invest (2000) 1.02
Value of smear and PCR in bronchoalveolar lavage fluid in culture positive pulmonary tuberculosis. Eur Respir J (2005) 1.01
Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion. Ann Intern Med (1996) 1.00
Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007. Infection (2009) 1.00
Factors associated with rifampin resistance in staphylococcal periprosthetic joint infections (PJI): a matched case-control study. Infection (2012) 1.00
Antimicrobial treatment concepts for orthopaedic device-related infection. Clin Microbiol Infect (2012) 1.00
Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection. BMJ (1999) 1.00
Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed. J Am Acad Dermatol (1998) 0.99
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. World J Urol (2013) 0.98
Emergence of four cases of KPC-2 and KPC-3-carrying Klebsiella pneumoniae introduced to Switzerland, 2009-10. Euro Surveill (2011) 0.98
The origin and function of soluble CD14 in experimental bacterial meningitis. J Immunol (1999) 0.98
Eosinophilia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1997) 0.98
Low occurrence of Clostridium difficile in fecal samples of healthy calves and pigs at slaughter and in minced meat in Switzerland. J Food Prot (2010) 0.97
Corynebacterium confusum sp. nov., isolated from human clinical specimens. Int J Syst Bacteriol (1998) 0.97
Comparison of BacT/ALERT 3D, Lowenstein-Jensen medium and Middlebrook 7H10/7H11 biplate for recovering mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis (2005) 0.96
Differential infectivity of Plasmodium for mosquitoes. Parasitol Today (1988) 0.96